High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis

High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis

Background: This study explores the association of neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR), and platelet-to-lymphocyte (PLR) ratios with the 3-month treatment response and persistence of tumor necrosis factor-alpha (TNF-α) blockers in patients with ankylosing spondylitis (AS). M...

Full description

Bibliographic Details
Main Authors: Dong-Hyuk Moon, Aran Kim, Byung-Wook Song, Yun-Kyung Kim, Geun-Tae Kim, Eun-Young Ahn, Min-Wook So, Seung-Geun Lee
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceuticals
Subjects:
ankylosing spondylitis (AS)
tumor necrosis factor-alpha (TNF-α)
treatment outcome
blood cells
biomarkers
Online Access:https://www.mdpi.com/1424-8247/16/3/379

Internet

https://www.mdpi.com/1424-8247/16/3/379

Similar Items